FY 2026 improper payment rate estimates for Medicare, MA programs
CMS released several improper payment estimates for fiscal year (FY) 2026, highlighting payment accuracy issues across Medicare, Medicare Advantage (MA), and other programs.
Improper payments include overpayments, underpayments, and payments for which there is insufficient information to discern whether program requirements were met.
The estimated FY 2026 improper payment rate for original Medicare is 7.32% ($33.96 billion), up from 6.55% ($28.83 billion) in FY 2025. This marks the tenth consecutive year that this metric has remained below the 10% threshold for compliance, according to CMS.
CMS estimates that 5.68% ($23.86 billion) of MA payments were improper in FY 2026, down slightly from the FY 2025 reported rate of 6.09% ($23.67 billion). The agency attributed most of these improper payments to MA organizations’ supporting documentation failing to substantiate the diagnosis data submitted for payment.
Improper payment rates also seemingly declined across Part D. CMS estimates that 3.85% ($5.16 billion) of these payments were improper in FY 2026, compared to approximately 4% ($4.23 billion) in the previous FY. Most of these payment issues occurred because plan sponsors did not provide sufficient documentation to support prescription data used for payment determinations, according to the agency.
The estimated FY 2026 improper payment rates for Medicaid and the Children’s Health Insurance Program were 7.08% ($46.84 billion) and 9.81% ($2.26 billion), respectively. Both estimates were higher than their reported FY 2025 rates, with CMS attributing the majority of improper payments to insufficient documentation.
The agency is launching several initiatives to strengthen program integrity, including enhanced provider enrollment controls, payment suspensions, expanded data analytics, and improved claims monitoring. CMS expects these efforts to begin affecting improper payment rates in FY 2027, but more substantial impacts may not be seen until FY 2028.